Bristol Myers Squibb (BMY) FCF Payout Ratio (2009 - 2026)

Bristol Myers Squibb has disclosed FCF Payout Ratio across 18 years of filings, most recently posting 1.69 for Q1 2026.

• In Q1 2026, FCF Payout Ratio rose 128.23% year-over-year to 1.69; the TTM figure through Mar 2026 stood at 0.43 (up 13.5% YoY), while the FY2025 annual figure was 0.39, up 12.6% from the prior year.
• FCF Payout Ratio advanced to 1.69 in Q1 2026, from 0.79 in the prior quarter.
• Over the last five years, FCF Payout Ratio for BMY reached as high as 1.69 in Q1 2026 and fell as low as 0.01 in Q2 2022.
• The 5-year median for FCF Payout Ratio is 0.35 (2025), against an average of 0.48.
• Annual changes were most pronounced in 2023 — FCF Payout Ratio surged 12086.9% — and 2025, when it sank 39.81%.
• A 5-year view of FCF Payout Ratio shows it stood at 0.39 in 2022, then fell by 23.54% to 0.3 in 2023, then gained by 1.41% to 0.3 in 2024, then jumped by 162.33% to 0.79 in 2025, then surged by 115.41% to 1.69 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 1.69, 0.79, and 0.21 for Q1 2026, Q4 2025, and Q3 2025 respectively.